The world's first oncolytic virus product for the treatment
2021-11-05
On November 1, 2021, Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) announced that the oncolytic virus product Delytact (teserpaturev/G47∆) has been approved to the Ministry of Health
LEARN MORE